BMS Clinical Trial Information [clinicaltrials_resource:cea6adb53f1855d759c532f4a5cc7e37]
A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir) [clinicaltrials:NCT00002028]Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine [clinicaltrials:NCT00002035]Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients [clinicaltrials:NCT00002041]Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC [clinicaltrials:NCT00002057]A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia [clinicaltrials:NCT00002067]A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients [clinicaltrials:NCT00002168]A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection [clinicaltrials:NCT00002176]A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection [clinicaltrials:NCT00002177]A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients [clinicaltrials:NCT00002207]Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI) [clinicaltrials:NCT00002224]Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs [clinicaltrials:NCT00002240]A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex [clinicaltrials:NCT00002246]A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers [clinicaltrials:NCT00002261]A Study of ddI in Patients With AIDS Who Become Sicker While Taking Zidovudine [clinicaltrials:NCT00002274]A Study of ddI in Children With AIDS Who Have Not Had Success With Zidovudine [clinicaltrials:NCT00002280]A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes [clinicaltrials:NCT00002293]A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition [clinicaltrials:NCT00002300]A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients [clinicaltrials:NCT00002307]A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs [clinicaltrials:NCT00002308]The Safety and Effectiveness of Megace in HIV-Infected Women [clinicaltrials:NCT00002345]A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection. [clinicaltrials:NCT00002349]A Study of Lobucavir in Patients With AIDS [clinicaltrials:NCT00002352]A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV [clinicaltrials:NCT00002358]A Study Comparing Two Forms of Didanosine in HIV-infected Patients [clinicaltrials:NCT00002360]A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [clinicaltrials:NCT00002369]The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine [clinicaltrials:NCT00002371]A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs [clinicaltrials:NCT00002411]Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen [clinicaltrials:NCT00002429]Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment [clinicaltrials:NCT00004584]Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients [clinicaltrials:NCT00005918]A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine [clinicaltrials:NCT00013897]A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor [clinicaltrials:NCT00028067]Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s) [clinicaltrials:NCT00028301]A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy [clinicaltrials:NCT00035516]A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis [clinicaltrials:NCT00035529]A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes. [clinicaltrials:NCT00035542]clinicaltrials:NCT00035555A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes [clinicaltrials:NCT00035568]A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen [clinicaltrials:NCT00035633]A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen [clinicaltrials:NCT00035789]
link [clinicaltrials_vocabulary:link]
BMS Clinical Trial Information [clinicaltrials_resource:cea6adb53f1855d759c532f4a5cc7e37]
Bio2RDF identifier
cea6adb53f1855d759c532f4a5cc7e37
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:cea6adb53f1855d759c532f4a5cc7e37
url [clinicaltrials_vocabulary:url]
identifier
clinicaltrials_resource:cea6adb53f1855d759c532f4a5cc7e37
title
BMS Clinical Trial Information
@en
BMS Clinical Trials Disclosure
@en
type
label
BMS Clinical Trial Information [clinicaltrials_resource:cea6adb53f1855d759c532f4a5cc7e37]
@en
BMS Clinical Trials Disclosure [clinicaltrials_resource:cea6adb53f1855d759c532f4a5cc7e37]
@en